Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Pomalidomide“
Suchtreffer
Begriffe & Kennungen
Pomalidomide Teva · 4.5 · Effect of other medicinal products on pomalidomide
Eintrag öffnenPomalidomide Teva · 4.5 · Effect of pomalidomide on other medicinal products
Eintrag öffnenPomalidomide Teva · 4.5 · Pomalidomide is not anticipated to cause clinically relevant pharmacokinetic interactions due to P450 isoenzym
Eintrag öffnenPomalidomide Teva · 4.5 · Pomalidomide is partly metabolised by CYP1A2 and CYP3A4/5. It is also a substrate for P-glycoprotein. Co-admin
Eintrag öffnenPomalidomide Teva · 4.5 · The effect of dexamethasone on warfarin is unknown. Close monitoring of warfarin concentration is advised duri
Eintrag öffnenPomalidomide Teva · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenPomalidomide Teva · 4.8 Undesirable effects · 1
Eintrag öffnenPomalidomide Teva · 4.8 · 15 pomalidomide.
Eintrag öffnenPomalidomide Teva · 4.8 · 16 Combination of Pomalidomide/ Pomalidomide/ treatment bortezomib/dexamethasone dexamethasone System Organ Cl
Eintrag öffnenPomalidomide Teva · 4.8 · 19 Combination of Pomalidomide/ Pomalidomide/ treatment bortezomib/dexamethasone dexamethasone System Organ Cl
Eintrag öffnenPomalidomide Teva · 4.8 · 21 Reporting of suspected adverse reactions
Eintrag öffnenPomalidomide Teva · 4.8 · Adverse reactions tended to occur more frequently within the first 2 cycles of treatment with
Eintrag öffnenPomalidomide Teva · 4.8 · Allergic reactions and severe skin reactions Angioedema, anaphylactic reaction and severe cutaneous reactions
Eintrag öffnenPomalidomide Teva · 4.8 · Description of selected adverse reactions
Eintrag öffnenPomalidomide Teva · 4.8 · Febrile neutropenia (FN) was reported in 3.2% (Pom+Btz+Dex) patients and 6.7% (Pom+Dex) patients and was serio
Eintrag öffnenPomalidomide Teva · 4.8 · Frequencies are defined in accordance with current guidance, as: very common (≥1/10), common (≥1/100 to <1/10)
Eintrag öffnenPomalidomide Teva · 4.8 · Haemorrhage Haemorrhagic disorders have been reported with pomalidomide, especially in patients with risk fact
Eintrag öffnenPomalidomide Teva · 4.8 · Infection Infection was the most common non haematological toxicity.
Eintrag öffnenPomalidomide Teva · 4.8 · Infection occurred in 83.1% (Pom+Btz+Dex) patients and 55.0% (Pom+Dex) patients (34.9% (Pom+Btz+Dex) and 24.0%
Eintrag öffnenPomalidomide Teva · 4.8 · Neutropenia and thrombocytopenia Neutropenia occurred in up to 54.0% (Pom+Btz+Dex) patients (47.1% (Pom+Btz+De
Eintrag öffnen